Celebrating 40 years 

Honoring the past. 

Embracing the future.

Your contributions support and sustain us as we educate, advocate, and integrate.

Join us as we improve perinatal care... together.  

2020 Conference

SAVE the DATE: April 1 - 3, 2020

Perinatal Care and the 4th Trimester: 

Redefining Prenatal, Postpartum, and Neonatal Care for a New Generation

at Children's Hospital Colorado


We are proud to share NPA's most recent publications:


NPA members can subscribe to the  Journal of Perinatology at the discounted rate of $75 (retail $195) . 

NPA MEMBERSHIP BEGINS AT:   $45 for students and parents   $75 for professionals.


Free Webinars in November and December

Worldwide Webinar Series on Prematurity Awareness

with Preemie Parents from Australia, Brazil, Canada, Gambia, Ireland   

Brought to you by NPA's Family Advocacy Network (FAN) in collaboration with the Preemie Parent Alliance (PPA). 

BECOME A MEMBER and attend the all the webinars in our series for free. 

Free Resources

Late Preterm Infants

Access the Multidisciplinary Guidelines for the Care of Late Preterm Infants

Read the original publication in Journal of Perinatology 2013 Jul; 33(Suppl 2).

Perinatal Substance Use and Neonatal Opioid Withdrawal


See all of NPA's resources on perinatal substance use.

Respiratory Syncytial Virus Guidelines

2018 Respiratory Syncytial Virus Prevention Guidelines can be accessed at Neonatology Today

The National Perinatal Association has recently revised the guidelines for the prevention and treatment of RSV in babies born prematurely who are at risk for the more serious consequences of RSV.

Learn more about protecting fragile infants from RSV.

Parent Support  

See our resources for promoting the psychosocial support of NICU families and staff, including a Free Download of our booklet, Starting and Sustaining a Peer Support Program for NICU Parents  when you visit support4NICUparents.org.


NPA Submits a Letter to the FDA -This April the National Perinatal Association submitted a statement to the Gastrointestinal Drugs Advisory Committee and the Pediatric Advisory Committee of the FDA in support of new innovations in treatment for infants with hyperbilirubemia . Read our statement here

The Development of New Pharmacological Therapies for Infants - The National Perinatal Association’s Position of Support for Senate Bill S.2041 - Promoting Life-Saving New Therapies for Neonates Act of 2016 by Sue Hall, MD; Raylene Phillips, MD; Vincent C. Smith, MD; Cris Glick, MD; Mitchell Goldstein, MD; T. Allen Merritt, MD

© 2018 National Perinatal Association
Powered by Wild Apricot Membership Software